German Renewable Energy Stock News

In recent days, Mercedes-Benz Group AG agreed with labor representatives to pursue deeper cost reductions and push toward 70% internal AI tool adoption by year-end, aiming to streamline operations amid a tougher global car market. This accelerated use of artificial intelligence across the workforce highlights how Mercedes-Benz is trying to reshape its cost base and workflow efficiency rather than relying solely on new model launches. We’ll now examine how Mercedes-Benz’s push for deeper...

Jungheinrich (XTRA:JUN3) has just shifted index tiers, leaving the Germany MDAX Index, Performance, on 19 June 2026 and joining the Germany SDAX, Total Return, on 22 June, which has prompted renewed attention on the stock. See our latest analysis for Jungheinrich. The recent index changes appear to have coincided with share price pressure, with Jungheinrich’s stock down 35.77% on a year to date share price return and the 1 year total shareholder return declining 41.41%. This suggests momentum...

In recent days, Nordex SE reported securing three new wind turbine orders in the United States totaling 484 MW and an additional 112 MW order in Germany, spanning its N133/4.8 and N163/5.X platforms for undisclosed customers and projects. Taken together, these large contracts highlight ongoing demand for Nordex’s onshore turbine technology across both its core European base and an increasingly important U.S. market. We’ll now examine how this fresh 596 MW of orders could influence Nordex’s...

U.S. Supreme Court issues a landmark ruling that significantly limits Bayer's liability in Roundup litigation. Decision curbs tens of thousands of failure to warn claims tied to the Roundup herbicide. Ruling is expected to reshape legal risk for Bayer, ticker XTRA:BAYN, and could influence future product liability cases across the sector. Bayer, listed as XTRA:BAYN, operates across pharmaceuticals, consumer health and crop science, with Roundup long tied to its agricultural business. The...

Infineon Technologies (XTRA:IFX) is back in focus after China’s Supreme People’s Court upheld an injunction on its Gallium Nitride products. This ruling blocks related sales in mainland China and closes a long running patent dispute with Innoscience. See our latest analysis for Infineon Technologies. Despite the legal setback on its GaN products in China, Infineon Technologies’ share price has moved to €82.01, with a 90 day share price return of 119.10% and a 1 year total shareholder return...

Siemens Healthineers (XTRA:SHL) is under pressure after the Unified Patent Court in Germany ruled that its latest mammography system infringes Hologic’s focusing technology, triggering injunctions, recalls and refund obligations across key European markets. See our latest analysis for Siemens Healthineers. At a share price of €34.4, Siemens Healthineers has seen its short term share price return soften over recent months, while the 1 year total shareholder return has also declined. This...

Germany’s sheltered workshop system is facing a legal test that could reshape labor costs for hundreds of outsourcing partners. For investors, that means some German industrials and consumer goods stocks with exposure to these workshops could see their cost structures change, for better or worse, as minimum wage requirements are debated. This article looks at 3 stocks from a focused German Outsourcing Exposed Industrials and Consumer Goods screener that could be positively affected if they...

With the business potentially at an important milestone, we thought we'd take a closer look at Planethic Group AG's...

It looks like UmweltBank AG ( ETR:UBK ) is about to go ex-dividend in the next 4 days. Typically, the ex-dividend date...

Allgeier SE ( ETR:AEIN ) is about to trade ex-dividend in the next four days. The ex-dividend date is commonly two...

ADM Hamburg (DB:OEL) has kicked off FY 2025 with first half revenue of €207.5 million and EPS of €6.48, set against trailing twelve month earnings growth of 260.1% and a net profit margin of 0.3% versus 0.06% a year earlier. The company has seen revenue move from €247.7 million in the first half of 2024 to €182.4 million in the second half of 2024 and then to €207.5 million in the first half of 2025. EPS shifted from €1.31 to a loss of €0.97 and then to €6.48 over the same periods. With multi...

LEG Immobilien (XTRA:LEG) has completed its scrip dividend for the 2025 financial year, with about €63.1 million reinvested and roughly 1.28 million new shares issued, modestly expanding the company’s equity base. See our latest analysis for LEG Immobilien. LEG Immobilien’s latest scrip dividend comes as the stock trades at €55.2, with a 1 day share price return of 2.32% and a year to date share price return down 10.10%, while the 3 year total shareholder return is positive at 22.97% despite...

Without a specific news event as a catalyst, Allianz (XTRA:ALV) draws attention today mainly through its current share price of €407.10 and its recent total return profile for investors. See our latest analysis for Allianz. The recent 4.68% 30 day share price return and 16.02% 90 day share price return suggest momentum has been building in Allianz. At the same time, the 25.12% 1 year total shareholder return and 144.97% 5 year total shareholder return point to a strong longer term profile. If...

A new market research report on stem cell culture media has put Sartorius (XTRA:SRT3) in focus, highlighting the company as a key participant as pharmaceutical and biotechnology groups expand their use of stem cell technologies. See our latest analysis for Sartorius. Sartorius shares, which last closed at €219.4, have had a mixed run, with the 1-year total shareholder return of 2.88% contrasting with weaker multi year figures. This suggests recent momentum is stabilising after earlier...

Europe’s new biometric border controls are turning into a stress test for travel infrastructure, with reports of hours long queues and potential flight disruption at major hubs. For investors, the question is how this kind of operational strain might ripple through stocks that depend on smooth airport throughput and passenger flows. This article looks at three European Travel Disruption stocks that appear more exposed to the EES turmoil, and why the current situation could weigh on their...

The euro’s sharp slide, weaker Eurozone data, and softer rate hike expectations are reshaping the risk profile for some of the region’s most policy sensitive stocks. Lower energy costs and a stronger US dollar are not a simple win or loss for investors, as they can pressure margins, earnings quality, and valuations in different ways. This article focuses on the downside by spotlighting 3 Eurozone Sensitive Stocks Impacted by Weak Currency and Rate Outlook that screen as particularly exposed...

Carl Zeiss Meditec (XTRA:AFX) is back in focus after ZEISS Medical Technology disclosed two recent partnership agreements, one centered on virtual reality glaucoma testing and another on deploying VISUMAX 800 lasers across Aier Eye Hospital’s network. See our latest analysis for Carl Zeiss Meditec. The recent virtual reality glaucoma collaboration and VISUMAX 800 rollout news arrives as Carl Zeiss Meditec shares trade at €27.76, with short term momentum reflected in a 7 day share price return...

It looks like InnoTec TSS AG ( FRA:TSS ) is about to go ex-dividend in the next three days. Typically, the ex-dividend...

Readers hoping to buy Nagarro SE ( ETR:NA9 ) for its dividend will need to make their move shortly, as the stock is...

GEA Group (XTRA:G1A) has drawn fresh investor attention after presenting its 2030 strategy, which outlines goals for revenue above €7b, higher EBITDA margins, expanded service and digital sales, and sizeable cost savings. See our latest analysis for GEA Group. GEA Group's new 2030 plan lands after a mixed year for the stock, with a 7.21% 1 month share price return but a 2.06% decline over 3 months, set against a 66.49% 3 year total shareholder return that points to longer term momentum. If...

Readers hoping to buy Dermapharm Holding SE ( ETR:DMP ) for its dividend will need to make their move shortly, as the...

PUMA (XTRA:PUM) is back in focus after fresh product and branding activity, including the PUMA NITRO Lab launch in Los Angeles and strong athlete showings at the 2026 HYROX World Championships. See our latest analysis for PUMA. PUMA's recent marketing and product launches come as the stock trades at €26.66, with a 23.65% 90 day share price return suggesting momentum has picked up again despite a weaker 30 day share price return and a mixed multi year total shareholder return profile. If this...

adidas (XTRA:ADS) stock is in focus after two fresh product moves, as the company pushes into professional workwear with the ADIDAS PRO WORK safety footwear range and taps gaming fans through its collaboration with Brawl Stars. See our latest analysis for adidas. Those product launches land at a time when momentum in adidas stock has been firming up, with a 30 day share price return of 11.50% and a 90 day share price return of 31.25%. This comes even as the 1 year total shareholder return is...

Bayer (XTRA:BAYN) is back in focus after U.S. regulators approved its new MRI contrast agent AMBELVIST, and the company moved forward on multiple fronts in research partnerships and oncology development. See our latest analysis for Bayer. Recent gains around the AMBELVIST approval and AI drug discovery partnership come on top of a 4.96% 7 day share price return and a 50.41% total shareholder return over the past year, while longer term total shareholder returns over three and five years...